• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Aranscia Acquires Spesana to Advance Precision Oncology

by Fred Pennic 05/12/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Spesana logo

What You Should Know: 

– Aranscia, a global provider of award-winning clinical workflow and diagnostic technology solutions announced its strategic acquisition of Spesana and its best-in-class suite of patient navigation, clinical collaboration, and oncology clinical decision support utilities. 

– As part of the acquisition, Spesana’s Founder and CEO, Carla Balch, a renowned pioneer in healthcare and oncology information systems, will assume the role of Executive Director across all Aranscia software solutions. This includes overseeing Spesana’s continued commercial and technical expansion.

Spesana: Streamlining Precision Medicine and Oncology Care

Founded in 2019, Spesana has developed a healthcare platform designed to increase the velocity, efficiency, and utility of innovative precision medicine programs. The company’s solutions are currently utilized across more than 140 clinical sites.

Spesana’s platform offers a comprehensive suite of tools, including patient navigation, prior authorization assistance, clinical trial collaboration features, and diagnostic workflow solutions. Its blue-chip customer base comprises leading payers, multi-site provider and oncology organizations, and diagnostic laboratories. Clients using Spesana’s intelligent platform utilities have reported significant benefits, including a notable 60% improvement in the appropriate use of precision medicine diagnostics by eliminating clinical overhead and process ambiguity.

Strategic Integration into Aranscia’s Precision Care Portfolio

The acquisition will see Spesana join Aranscia’s growing portfolio of companies, all of which share a synergistic mission focused on solving tactical gaps in clinical workflows and democratizing access to the advancements of precision care. This esteemed portfolio already includes:

  • 2bPrecise: An award-winning platform known for its lab-agnostic, EMR-integrated solutions that deliver unparalleled speed-to-value in implementing precision care.
  • YouScript: A widely recognized leader providing actionable, real-time personalized medication risk management and pharmacogenomics (PGx) insights.
  • AccessDx Laboratory: A CLIA-certified, CAP-accredited, and NYCQ molecular diagnostic laboratory with specialist expertise in PGx and other personalized diagnostics.

Carla Balch to Lead Software Solutions Expansion

The leadership of Carla Balch in her new role as Executive Director is a key component of the acquisition. Ms. Balch brings a wealth of experience and a pioneering track record in the healthcare technology sector, particularly in oncology. She was previously the President and CEO of Altos Solutions, which developed OncoEMR, the first web-based oncology electronic medical records company, later acquired by Flatiron Health (now part of Roche). Prior to founding Spesana, Ms. Balch also served as President of Nantcare, an oncology technology and clinical trials company, and as CEO of Inteliquet, an innovative clinical trial matching solution acquired by IQVIA. She currently serves on the Healthcare Counsel of the Federal Reserve Bank of St. Louis.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Healthcare Mergers & Acquisitions

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |